23776-83-2

Upstream product

• 23776-82-1 tert-butyl 2-(((benzyloxy)carbonyl)glycyl)hydrazine-1-carboxylate 
• 870-46-2 t-butoxycarbonylhydrazine 
• 1138-80-3 N-(Benzyloxycarbonyl)glycine 

Downstream Products

• 63793-25-9 (S)-3-Benzyloxycarbonylamino-N-[2-(N'-tert-butoxycarbonyl-hydrazino)-2-oxo-ethyl]-succinamic acid tert-butyl ester 
• 174276-42-7 Z-Arg(Tos)-Gly-NHNHBoc 
• 366792-99-6 N'-{[2-(benzyloxycarbonyl-methyl-amino)-acetylamino]-acetyl}-hydrazinecarboxylic acid tert-butyl ester 
• 1243204-99-0 tert-butyl 2-({[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzoyl]amino}acetyl)hydrazinecarboxylate 
• 944896-90-6 C-[5-(4-chloro-phenyl)-2H-[1,2,4]triazol-3-yl]-methylamine 
• 100350-55-8 H-Asp(OBzl)-Val-Tyr-Gly-N₂H₂Boc*TFA 
• 100350-53-6 Ddz-Asp(OBzl)-Val-Tyr-Gly-N₂H₂Boc 
• 100350-49-0 Z-Val-Tyr-Gly-N₂H₂Boc 
• 100350-50-3 H-Val-Tyr-Gly-N₂H₂Boc 
• 51952-36-4 H-Tyr-Gly-N₂H₂Boc 
• 366793-03-5 C₄₉H₆₈Cl₃N₉O₁₆ 
• 366793-00-2 3-{benzyloxy-[({[2-(N'-tert-butoxycarbonyl-hydrazino)-2-oxo-ethylcarbamoyl]-methyl}-methyl-carbamoyl)-methyl]-carbamoyl}-tetrahydro-pyridazine-1,2-dicarboxylic acid 1-benzyl ester 2-(9H-fluoren-9-ylmethyl) ester 
• 366793-01-3 3-{benzyloxy-[({[2-(N'-tert-butoxycarbonyl-hydrazino)-2-oxo-ethylcarbamoyl]-methyl}-methyl-carbamoyl)-methyl]-carbamoyl}-tetrahydro-pyridazine-1-carboxylic acid benzyl ester 
• 100350-48-9 Z-Tyr(Z)-Gly-N₂H₂Boc 

Relevant academic research and scientific papers

POLYMERIC CONJUGATES AND USES THEREOF

Polymeric conjugates comprising a polymeric matrix having associated therewith an agent that down-regulates an activity or expression of a polypeptide associated with onset or progression of melanoma, and optionally and preferably, an additional agent that acts in synergy with said agent, are provided. Synthetic methodologies for preparing these conjugates and uses thereof in treating melanoma and other cancerous diseases are also provided.

NOVEL PHENYL IMIDAZOLES AND PHENYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed

Amino acids and peptides. XXV. Preparation of fibronectin-related peptide poly(ethylene glycol) hybrids and their inhibitory effect on experimental metastasis

Hybrids of fibronectin-related peptides [Arg-Gly-Asp (RGD), Arg-Gly-Asp- Ser (RGDS)] and poly(ethylene glycol) (PEG) were prepared and their inhibitory effects on experimental metastasis in mice were examined. The inhibitory effect of RGD was markedly pot